AstraZeneca, ePhysician Team Up to Promote Electronic Prescription Writing Systems
The U.S. division of the British drug maker AstraZeneca PLC and ePhysician Inc. are expected to announce today a three-year deal to promote to doctors ePhysician's electronic prescription-writing systems, the Wall Street Journal reports. The program will provide at least 500 doctors with hand-held devices that will run ePhysician's program and provide access to detailed information about AstraZeneca products and independently produced reference material about other drugs. The alliance represents the "latest in a series of pacts between pharmaceutical companies and makers of electronic prescribing systems" and "reflects a growing interest by drug makers in using Internet technology to market their drugs," the Journal reports (Carrns, Wall Street Journal, 4/24).
This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.